Investor Alert

Market Pulse Archives

July 8, 2021, 6:38 a.m. EDT

Sight Sciences sets terms for IPO, to raise up to $160.5 million

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Sight Sciences Inc. (SGHT)
  • X
    Renaissance IPO ETF (IPO)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Sight Sciences Inc. /zigman2/quotes/227983089/composite SGHT -2.79% has set terms of its initial public offering, which could value the California-based ophthalmology and optometry company at up to $971.7 million. The company is looking to raise up to $160.54 million, as it is offering 6.98 million shares in the IPO, which is expected to price between $20 and $23 a share. The company plans to use the proceeds from the IPO to fund clinical trials for OMNI and TearCare, for sales and marketing of its products and for research and development. The stock is expected to list on the Nasdaq under the ticker symbol "SGHT." Morgan Stanley and BofA Securities are the lead underwriters. The company reported a first-quarter net loss of $12.2 million on revenue of $8.6 million, after a loss of $9.2 million on revenue of $6.5 million in the same period a year ago. The company is looking to go public at a time that the Renaissance IPO ETF /zigman2/quotes/207665280/composite IPO -3.85% has slipped 0.8% over the past three months while the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.84% has gained 6.4%.

US : U.S.: Nasdaq
$ 20.90
-0.60 -2.79%
Volume: 210,216
Dec. 3, 2021 4:00p
P/E Ratio
Dividend Yield
Market Cap
$988.73 million
Rev. per Employee
US : U.S.: NYSE Arca
$ 57.41
-2.30 -3.85%
Volume: 161,171
Dec. 3, 2021 4:00p
-38.67 -0.84%
Volume: 2.71B
Dec. 3, 2021 5:35p

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.